These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32838715)

  • 1. Recent Advances in the Scaffold Engineering of Protein Binders.
    Ahmadi MKB; Mohammadi SA; Makvandi M; Mamouei M; Rahmati M; Dehghani H; Wood DW
    Curr Pharm Biotechnol; 2021; 22(7):878-891. PubMed ID: 32838715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.
    Li D; Gong R; Zheng J; Chen X; Dimitrov DS; Zhao Q
    Biochem Biophys Res Commun; 2017 Apr; 485(2):446-453. PubMed ID: 28202413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alternative scaffold proteins].
    Petrovskaia LE; Shingarova LN; Dolgikh DA; Kirpichnikov MP
    Bioorg Khim; 2011; 37(5):581-91. PubMed ID: 22332353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering bispecificity into a single albumin-binding domain.
    Nilvebrant J; Alm T; Hober S; Löfblom J
    PLoS One; 2011; 6(10):e25791. PubMed ID: 21991353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered proteins as specific binding reagents.
    Binz HK; Plückthun A
    Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
    Ebersbach H; Fiedler E; Scheuermann T; Fiedler M; Stubbs MT; Reimann C; Proetzel G; Rudolph R; Fiedler U
    J Mol Biol; 2007 Sep; 372(1):172-85. PubMed ID: 17628592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
    Rouet R; Dudgeon K; Christie M; Langley D; Christ D
    J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing antibodies: engineering new binding proteins.
    Banta S; Dooley K; Shur O
    Annu Rev Biomed Eng; 2013; 15():93-113. PubMed ID: 23642248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
    Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
    Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering antibodies by yeast display.
    Boder ET; Raeeszadeh-Sarmazdeh M; Price JV
    Arch Biochem Biophys; 2012 Oct; 526(2):99-106. PubMed ID: 22450168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
    Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
    MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanization of antibodies.
    Almagro JC; Fransson J
    Front Biosci; 2008 Jan; 13():1619-33. PubMed ID: 17981654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification, and characterization of engineered antibody CH2 and VH domains.
    Gong R; Chen W; Dimitrov DS
    Methods Mol Biol; 2012; 899():85-102. PubMed ID: 22735948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of phage-displayed cystine-stabilized mini-protein libraries for proteinaceous binder engineering.
    Chang HJ; Yang AS
    Methods Mol Biol; 2014; 1088():1-17. PubMed ID: 24146393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.